Obesity among schoolchildren of different socioeconomic levels in a developing country

Insights

Obesity in children is a growing concern, with a 16.7% prevalence found in this Brazilian study. Unlike developed nations, childhood obesity in Ribeirão Preto correlated positively with higher socioeconomic levels.

Area of Science:

  • Pediatrics
  • Public Health
  • Nutritional Epidemiology

Background:

  • Obesity is a global health issue linked to increased morbidity and mortality.
  • Rising obesity prevalence is observed worldwide.
  • In developed countries, obesity is often associated with lower socioeconomic status.

Purpose of the Study:

  • To determine the prevalence of obesity in children aged 84 to 143 months.
  • To investigate the relationship between socioeconomic level and childhood obesity in Ribeirão Preto, Brazil.

Main Methods:

  • A cross-sectional study involving 300 children from three socioeconomic strata.
  • Measurements included weight, height, arm circumference, and triceps skinfold.
  • Data analysis to determine obesity and malnutrition prevalence across socioeconomic groups.

Main Results:

  • The overall prevalence of obesity was 16.7%.
  • Obesity prevalence was highest in the high socioeconomic group (38%), followed by middle (12%) and low (4%).
  • Malnutrition prevalence was 8.3%.

Conclusions:

  • Childhood obesity prevalence in Ribeirão Preto is comparable to developed countries.
  • A significant positive correlation exists between socioeconomic level and childhood obesity in this Brazilian population, contrasting with findings in developed nations.

Related Concept Videos

Cross-Sectional Research01:50

Cross-Sectional Research

In cross-sectional research, a researcher compares multiple segments of the population at the same time. If they were interested in people's dietary habits, the researcher might directly compare different groups of people by age. Instead of following a group of people for 20 years to see how their dietary habits changed from decade to decade, the researcher would study a group of 20-year-old individuals and compare them to a group of 30-year-old individuals and a group of 40-year-old...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Socioemotional Experience and Gender Development01:30

Socioemotional Experience and Gender Development

Social-emotional experiences and cultural influences play significant roles in shaping gender development. During middle childhood, from ages 6 to 11, peer groups become dominant in reinforcing gender norms. Children in this age group often align with same-gender peer groups, which actively encourage behaviors that conform to traditional gender roles. For instance, boys may be discouraged from engaging in activities perceived as feminine, reinforcing culturally dictated norms about masculinity...